簡介

本頁面提供了有關 Adam H Schechter 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Adam H Schechter已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:DVA / DaVita Inc. Director 5,692
US:LH / Labcorp Holdings Inc. President & CEO, Director 107,234
US:MRK / Merck & Co., Inc. EVP & Pres-Global Human Health 0
如何解讀這些圖表

以下圖表顯示了在Adam H Schechter進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Adam H Schechter 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-05-18 2026-05-15 4 DVA DAVITA INC.
Common Stock
A - Award 250 5,692 4.59
2026-05-13 2026-05-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -5,903 107,234 -5.22 254.50 -1,502,314 27,291,053
2026-03-30 2026-03-26 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -26,106 113,137 -18.75 268.38 -7,006,328 30,363,708
2026-03-30 2026-03-26 4 LH LABCORP HOLDINGS INC.
Common Stock
A - Award 58,470 139,243 72.39
2026-03-17 2026-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 332 5,442 6.50
2026-03-05 2026-03-03 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale -8,705 80,773 -9.73 279.96 -2,437,047 22,613,169
2026-02-13 2026-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,521 89,478 -1.67 289.89 -440,923 25,938,777
2026-02-13 2026-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 3,656 90,999 4.19
2026-02-13 2026-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -5,273 87,343 -5.69 284.38 -1,499,536 24,838,602
2026-02-10 2026-02-09 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,352 92,616 -1.44 274.01 -370,462 25,377,710
2026-02-10 2026-02-07 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 3,249 93,968 3.58
2026-02-10 2026-02-06 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,315 90,719 -1.43 277.20 -364,518 25,147,307
2026-02-10 2026-02-06 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 4,460 92,034 5.09
2025-11-17 2025-11-15 4 DVA DAVITA INC.
Common Stock
A - Award 411 5,110 8.75
2025-11-13 2025-11-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -5,745 87,574 -6.16 262.75 -1,509,499 23,010,068
2025-08-19 2025-08-15 4 DVA DAVITA INC.
Common Stock
A - Award 369 4,699 8.52
2025-08-13 2025-08-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -5,643 93,319 -5.70 266.78 -1,505,440 24,895,643
2025-05-16 2025-05-15 4 DVA DAVITA INC.
Common Stock
A - Award 348 4,330 8.74
2025-05-13 2025-05-12 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -6,105 98,962 -5.81 248.73 -1,518,497 24,614,818
2025-03-31 2025-03-27 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -13,584 105,067 -11.45 231.67 -3,147,005 24,340,872
2025-03-31 2025-03-27 4 LH LABCORP HOLDINGS INC.
Common Stock
A - Award 30,469 118,651 34.55
2025-03-18 2025-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 349 3,982 9.61
2025-02-13 2025-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,226 88,182 -1.37 245.14 -300,542 21,616,935
2025-02-13 2025-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 2,963 89,408 3.43
2025-02-13 2025-02-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -6,121 86,445 -6.61 244.62 -1,497,319 21,146,176
2025-02-10 2025-02-07 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,345 92,566 -1.43 246.27 -331,233 22,796,229
2025-02-10 2025-02-07 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 3,250 93,911 3.58
2025-02-10 2025-02-06 4 LH LABCORP HOLDINGS INC.
Common Stock
F - Taxes -1,240 90,661 -1.35 247.74 -307,198 22,460,356
2025-02-10 2025-02-06 4 LH LABCORP HOLDINGS INC.
Common Stock
M - Exercise 4,460 91,901 5.10
2024-11-19 2024-11-15 4 DVA DAVITA INC.
Common Stock
A - Award 312 3,633 9.39
2024-11-13 2024-11-11 4 LH LABCORP HOLDINGS INC.
Common Stock
S - Sale X -6,189 87,441 -6.61 243.47 -1,506,836 21,289,260
2024-08-19 2024-08-15 4 DVA DAVITA INC.
Common Stock
A - Award 333 3,321 11.14
2024-05-17 2024-05-15 4 DVA DAVITA INC.
Common Stock
A - Award 363 2,988 13.83
2024-03-29 2024-03-27 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -31,799 93,630 -25.35 216.57 -6,886,709 20,277,449
2024-03-29 2024-03-27 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 72,435 125,429 136.69
2024-03-19 2024-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 366 2,625 16.20
2024-02-13 2024-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,231 52,994 -2.27 227.45 -279,991 12,053,485
2024-02-13 2024-02-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,964 54,225 5.78
2024-02-08 2024-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,149 51,261 -2.19 223.71 -257,043 11,467,598
2024-02-08 2024-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,250 52,410 6.61
2024-02-06 2024-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -822 49,160 -1.64 221.54 -182,106 10,890,906
2024-02-06 2024-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,094 49,982 6.60
2023-11-17 2023-11-15 4 DVA DAVITA INC.
Common Stock
A - Award 529 2,259 30.58
2023-08-17 2023-08-15 4 DVA DAVITA INC.
Common Stock
A - Award 475 1,730 37.85
2023-05-17 2023-05-15 4 DVA DAVITA INC.
Common Stock
A - Award 516 1,255 69.82
2023-04-03 2023-03-30 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -18,646 46,888 -28.45 224.70 -4,189,756 10,535,734
2023-04-03 2023-03-30 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
A - Award 42,353 65,534 182.71
2023-03-17 2023-03-15 4 DVA DAVITA INC.
Common Stock
A - Award 658 739 812.35
2023-02-14 2023-02-13 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,170 23,181 -4.80 248.13 -290,312 5,751,902
2023-02-14 2023-02-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,656 24,351 12.24
2023-02-07 2023-02-06 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,368 21,695 -5.93 244.50 -334,476 5,304,428
2023-02-07 2023-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,507 23,063 17.93
2023-02-06 2023-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -805 19,556 -3.95 254.99 -205,267 4,986,584
2023-02-06 2023-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,773 20,361 15.77
2022-11-16 2022-11-15 4 DVA DAVITA INC.
Common Stock
A - Award 81 81
2022-11-03 2022-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -893 17,588 -4.83 222.56 -198,746 3,914,385
2022-11-03 2022-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,007 18,481 12.18
2022-09-29 3 DVA DAVITA INC.
No securities are beneficially owned
0
2022-02-15 2022-02-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 28,100 28,100
2022-02-15 2022-02-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 7,970 19,031 72.05
2022-02-08 2022-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -3,507 11,061 -24.07
2022-02-08 2022-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,412 16,474 -7.89 277.48 -391,802 4,571,206
2022-02-08 2022-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,507 17,886 24.39
2022-02-04 2022-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -2,773 14,568 -15.99
2022-02-04 2022-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -803 14,379 -5.29 273.18 -219,364 3,928,055
2022-02-04 2022-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,773 15,182 22.35
2021-11-03 2021-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -2,007 17,341 -10.37
2021-11-03 2021-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -886 12,409 -6.66 288.78 -255,859 3,583,471
2021-11-03 2021-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,007 13,295 17.78
2021-02-08 2021-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -3,506 19,348 -15.34
2021-02-08 2021-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -1,028 11,288 -8.35 223.78 -230,046 2,526,029
2021-02-08 2021-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 3,506 12,316 39.80
2021-02-04 2021-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 29,000 29,000
2021-02-04 2021-02-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 8,320 22,854 57.25
2020-11-04 2020-11-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -2,006 14,534 -12.13
2020-11-04 2020-11-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
F - Taxes -885 8,810 -9.13 207.23 -183,399 1,825,696
2020-11-04 2020-11-02 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 2,006 9,695 26.09
2020-02-14 2020-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,227 16,540 -6.91
2020-02-14 2020-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,227 7,689 18.99
2020-02-06 2020-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 45,600 45,600
2020-02-06 2020-02-04 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 10,520 17,767 145.16
2019-11-05 2019-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 65,100 65,100
2019-11-05 2019-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options
A - Award 24,800 24,800
2019-11-05 2019-11-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 6,020 7,247 490.63
2019-02-14 2019-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,227 1,227
2019-02-14 2019-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,038 0 -100.00
2019-02-14 2019-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,038 6,462 19.14
2019-02-14 2018-11-19 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
G - Gift -610 5,424 -10.11
2018-11-02 2018-11-01 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -277,879 0 -100.00
2018-11-02 2018-11-01 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -145,135 0 -100.00 73.66 -10,691,181
2018-11-02 2018-11-01 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -132,744 145,135 -47.77 73.98 -9,819,764 10,736,391
2018-11-02 2018-11-01 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 277,879 277,879 39.29 10,917,866 10,917,866
2018-09-18 2018-09-17 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -100,000 0 -100.00
2018-09-18 2018-09-17 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -7,360 55,406 -11.73 70.18 -516,511 3,888,286
2018-09-18 2018-09-17 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -100,000 0 -100.00 70.18 -7,017,780
2018-09-18 2018-09-17 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 100,000 100,000 36.56 3,656,000 3,656,000
2018-06-19 2018-06-18 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -100,000 100,000 -50.00
2018-06-19 2018-06-18 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -34,094 62,766 -35.20 61.00 -2,079,785 3,828,819
2018-06-19 2018-06-18 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -100,000 0 -100.00 61.00 -6,100,160
2018-06-19 2018-06-18 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 100,000 100,000 36.56 3,656,000 3,656,000
2018-05-08 2018-05-04 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
A - Award 139,063 139,063
2018-03-01 2018-02-27 4 MRK Merck & Co., Inc.
Common Stock
A - Award 34,094 34,094 54.72 1,865,624 1,865,624
2018-02-14 2018-02-12 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,038 1,038
2018-02-09 2018-02-08 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
S - Sale X -1,263 6,034 -17.31 169.29 -213,813 1,021,496
2018-02-09 2018-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,263 0 -100.00
2018-02-09 2018-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,263 7,297 20.93
2018-01-16 2018-01-16 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -50,994 200,000 -20.32
2018-01-16 2018-01-16 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -50,608 62,766 -44.64 61.63 -3,118,971 3,868,267
2018-01-16 2018-01-16 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -50,994 0 -100.00 61.63 -3,142,760
2018-01-16 2018-01-16 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 50,994 50,994 36.56 1,864,341 1,864,341
2017-12-18 2017-12-15 4 MRK Merck & Co., Inc.
Common Stock
G - Gift -750 113,374 -0.66
2017-05-09 2017-05-05 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
A - Award 162,625 162,625
2017-04-10 2017-02-27 4/A MRK Merck & Co., Inc.
Common Stock
A - Award 37,758 37,758 65.85 2,486,364 2,486,364
2017-04-04 2017-04-03 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -53,850 116,336 -31.64 63.48 -3,418,166 7,384,507
2017-03-01 2017-02-27 4 MRK Merck & Co., Inc.
Common Stock
A - Award 39,970 39,970 65.85 2,632,024 2,632,024
2017-02-13 2017-02-09 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,560 1,263 -55.26
2017-02-13 2017-02-09 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,560 6,034 34.87
2017-02-09 2017-02-07 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,263 2,823 80.96
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -26,135 0 -100.00
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -10,200 250,994 -3.91
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -36,335 0 -100.00 63.73 -2,315,699
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 10,200 36,335 39.03 36.56 372,912 1,328,408
2017-02-06 2017-02-03 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 26,135 26,135 33.49 875,261 875,261
2016-09-01 2016-09-01 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -39,200 26,135 -60.00
2016-09-01 2016-09-01 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -39,200 0 -100.00 62.61 -2,454,308
2016-09-01 2016-09-01 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 39,200 39,200 33.49 1,312,808 1,312,808
2016-07-01 2016-07-01 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -50,000 0 -100.00
2016-07-01 2016-07-01 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -50,000 0 -100.00 57.69 -2,884,415
2016-07-01 2016-07-01 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 50,000 50,000 44.30 2,215,000 2,215,000
2016-05-12 2016-05-10 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
A - Award 258,065 258,065
2016-03-15 2016-03-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,237 1,560 -44.23
2016-03-15 2016-03-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,237 4,474 38.21
2016-02-24 2016-02-22 4 MRK Merck & Co., Inc.
Common Stock
A - Award 37,223 37,223 50.77 1,889,812 1,889,812
2016-02-11 2016-02-09 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,560 2,797 126.11
2015-05-11 2015-05-11 4 MRK Merck & Co., Inc.
Common Stock
S - Sale -10,634 0 -100.00 60.44 -642,768
2015-05-05 2015-05-02 4 MRK Merck & Co., Inc.
Restricted Stock Unit
M - Exercise -19,343 0 -100.00 59.86 -1,157,872
2015-05-05 2015-05-02 4 MRK Merck & Co., Inc.
Common Stock
F - Taxes -8,709 10,634 -45.02 59.86 -521,321 636,551
2015-05-05 2015-05-02 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 19,343 19,343
2015-05-05 2015-05-01 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
A - Award 235,294 235,294
2015-03-13 2015-03-11 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,237 1,237
2015-02-25 2015-02-23 4 MRK Merck & Co., Inc.
Common Stock
A - Award 22,198 22,198 58.30 1,294,143 1,294,143
2015-02-12 2015-02-10 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,503 0 -100.00
2015-02-12 2015-02-10 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,503 3,237 86.68
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -19,200 0 -100.00
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -50,000 0 -100.00
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Common Stock
S - Sale X -74,200 0 -100.00 62.48 -4,636,224
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 5,000 74,200 7.23 34.47 172,350 2,557,674
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 19,200 69,200 38.40 35.09 673,728 2,428,228
2015-01-15 2015-01-15 4 MRK Merck & Co., Inc.
Common Stock
M - Exercise 50,000 50,000 44.19 2,209,500 2,209,500
2014-11-25 2014-11-24 4 MRK Merck & Co. Inc.
Phantom Stock
S - Sale -2,779 0 -100.00
2014-08-25 2014-08-25 4 MRK Merck & Co. Inc.
Common Stock
S - Sale X -22,000 70,795 -23.71 59.70 -1,313,380 4,226,396
2014-05-15 2014-05-13 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,503 1,503
2014-05-14 2014-05-14 4 MRK Merck & Co. Inc.
Common Stock
S - Sale X -10,527 0 -100.00 55.91 -588,584
2014-05-13 2014-05-09 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
A - Award 209,078 209,078
2014-05-12 2014-05-08 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
M - Exercise -1,593 0 -100.00
2014-05-12 2014-05-08 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
M - Exercise 1,593 1,734 1,129.79 98.96 157,643 171,597
2014-05-06 2014-05-04 4 MRK Merck & Co. Inc.
Restricted Stock Unit
M - Exercise -19,147 0 -100.00 58.22 -1,114,738
2014-05-06 2014-05-04 4 MRK Merck & Co. Inc.
Common Stock
F - Taxes -8,620 10,527 -45.02 58.22 -501,856 612,882
2014-05-06 2014-05-04 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 19,147 19,147
2014-02-26 2014-02-24 4 MRK Merck & Co. Inc.
Common Stock
A - Award 22,287 22,287 56.18 1,252,084 1,252,084
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -3,000 0 -100.00
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -2,500 0 -100.00
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -12,500 0 -100.00
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock - 401(k) Plan
I - Other -4,040 0 -100.00 55.70 -225,049
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock
S - Sale -18,000 0 -100.00 55.61 -1,000,935
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 2,500 18,000 16.13 47.39 118,475 853,020
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 3,000 15,500 24.00 45.41 136,230 703,855
2014-02-13 2014-02-11 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 12,500 12,500 48.24 603,000 603,000
2013-05-16 2013-05-08 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit
A - Award 1,593 1,593
2013-05-08 2013-05-07 4 MRK Merck & Co. Inc.
Restricted Stock Unit
M - Exercise -12,188 0 -100.00 44.98 -548,216
2013-05-08 2013-05-07 4 MRK Merck & Co. Inc.
Common Stock
F - Taxes -5,488 22,416 -19.67 44.98 -246,850 1,008,252
2013-05-08 2013-05-07 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 12,188 27,904 77.55
2013-05-08 2013-05-06 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
A - Award 244,767 244,767
2013-04-03 2013-04-01 4 LH LABORATORY CORP OF AMERICA HOLDINGS
Common Stock
A - Award 141 141
2013-02-27 2013-02-25 4 MRK Merck & Co. Inc.
Common Stock
A - Award 8,136 15,568 109.47 42.52 345,943 661,951
2013-02-20 2013-02-19 4 MRK Merck & Co. Inc.
Restricted Stock Unit
M - Exercise -10,670 0 -100.00 41.42 -441,951
2013-02-20 2013-02-19 4 MRK Merck & Co. Inc.
Common Stock
F - Taxes -3,238 7,432 -30.35 41.42 -134,118 307,833
2013-02-20 2013-02-19 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 10,670 10,670
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -5,000 0 -100.00
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
M - Exercise -61,200 0 -100.00
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Common Stock
S - Sale -56,300 14,900 -79.07 45.60 -2,567,257 679,434
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 5,000 71,200 7.55 28.42 142,100 2,023,504
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 5,000 66,200 8.17 31.84 159,200 2,107,808
2012-11-06 2012-11-05 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 61,200 61,200 23.45 1,435,140 1,435,140
2012-05-04 2012-05-02 4 MRK Merck & Co. Inc.
Stock Option (right to buy)
A - Award 277,879 277,879
2012-05-04 2012-05-02 4 MRK Merck & Co. Inc.
Restricted Stock Unit
A - Award 19,343 19,343
2012-04-26 2012-04-24 4 MRK Merck & Co. Inc.
Restricted Stock Unit
M - Exercise -11,475 0 -100.00 38.27 -439,148
2012-04-26 2012-04-24 4 MRK Merck & Co. Inc.
Common Stock
F - Taxes -4,535 7,035 -39.20 38.27 -173,554 269,226
2012-04-26 2012-04-24 4 MRK Merck & Co. Inc.
Common Stock
M - Exercise 11,475 11,570 12,089.51
2012-03-01 2012-02-28 4 MRK Merck & Co. Inc.
Common Stock
A - Award 9,194 9,194 38.38 352,866 352,866
2010-05-06 3 MRK Merck & Co. Inc.
Common Stock - 401(k) Plan
9,804
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)